Pancreatic and Hepatic Oncology Research
Moving in Cancer Discovery, Nature Reviews Drug Discovery and Neuron.
- Moved, week to 18 Nov 2026
- 3
- Papers in 60 days
- 79
Rebuilt
Moved this week
AI summary · may contain errors
Targeting RAS with newly available strategies is promising for pancreatic cancer interception because pancreatic precancers also carry KRAS mutations.
- In the news
AI summary · may contain errors
Reg proteins secreted by peritumoral exocrine acinar cells promote tumor innervation and perineural invasion in pancreatic ductal adenocarcinoma, linked to hyperinnervation and pain via the Reg-EXTL3 axis.
- 7 cites
Latest in Pancreatic and Hepatic Oncology Research
Newest first · last 60 days
AI summary · may contain errors
Non-phosphorylatable MAFA in Mafa4A/+ knock-in mice markedly increases MAFA stability and causes sex-specific pancreatic disease: males develop rapid glucose intolerance on HFD, while females develop hypoglycemia with inflammatory cystic ducts and MCNs.
- Open access
- 1 cites
AI summary · may contain errors
CD73 deletion in HNF1B-expressing metaplastic pancreatic epithelium during caerulein-induced chronic pancreatitis worsens injury and fibrosis and disrupts ADM recovery.
- Open access
AI summary · may contain errors
IL-18 depletion in genetically engineered mice with spontaneous pancreatic ductal adenocarcinoma suppresses tumor progression and prolongs survival, linked to STAT1-dependent immune evasion.
AI summary · may contain errors
HuR (ELAVL1) is enriched in human pancreatic ductal adenocarcinoma and negatively correlates with T-cell infiltration, and HuR loss enhances T-cell number and function in PDAC models.
- Open access
AI summary · may contain errors
In pancreatic ductal adenocarcinoma tumors from the PancFit trial, higher exercise is linked to fewer αSMA+ cells and fewer IL6-expressing iCAFs, alongside lower tumor IL6 expression.
AI summary · may contain errors
Adding toripalimab (PD-1 blockade) to modified FOLFIRINOX improves event-free survival in randomized phase II patients with borderline resectable or locally advanced pancreatic cancer, median 11.1 vs 9.6 months.
AI summary · may contain errors
In a cross-sectional cohort of 443 people with type 1 diabetes, 17% had low faecal elastase (<200 µg/g), and lower levels tracked with longer diabetes duration.
- Open access
- 1 cites
AI summary · may contain errors
Distinct stromal states in pancreatic ductal adenocarcinoma (PDAC) are linked to different biological functions and therapeutic vulnerabilities, offering a framework for patient stratification.
- Open access
- 2 cites
AI summary · may contain errors
PCC-driven propionyl-CoA catabolism is accelerated in human PDAC tumors and KPC mouse tumors, with PDAC patients showing decreased plasma propionyl-CoA intermediates.
AI summary · may contain errors
Dual inhibition of mTORC1/2 and Scd1 creates a synthetic-lethal vulnerability in pancreatic ductal adenocarcinoma, preventing adaptive PI3K/Akt rebound and improving anti-PD-1 synergy.
- Open access
AI summary · may contain errors
ANO6-dependent trogocytosis by cancer-associated fibroblasts transfers cholesterol-rich membrane lipids to pancreatic ductal adenocarcinoma cells, supporting their survival and growth.
- Open access
AI summary · may contain errors
Long-range chromatin interactions at non-coding PDAC risk loci nominate 273 candidate target genes, including a ~280 kb SOX9-linked interaction and a ~900 kb INHBA enhancer link.
- Open access
AI summary · may contain errors
Dual inhibition of DHODH and SLC29A1 in pancreatic ductal adenocarcinoma models suppresses tumor growth and metastatic burden while shifting the tumor microenvironment to a pro-inflammatory, immune-activated state.
- Open access
AI summary · may contain errors
Small-molecule RAS targeting is redefining treatment paradigms for pancreatic adenocarcinoma, an aggressive cancer with poor prognosis.
- Open access
AI summary · may contain errors
In orthotopic KPC pancreatic ductal adenocarcinoma, Tgfbr2-deficient mesothelin-targeted TCR-T cells gain restored IFNγ production and improved therapeutic efficacy when tumor pMHC-I is modestly increased.
- Open access
- 1 cites
AI summary · may contain errors
In pancreatic cancer patients (n=29) treated with LOAd703 plus chemotherapy, adaptive immune responses with increased CD40 expression are linked to longer survival, with CD40 as a central upregulated immune node.
- Open access
AI summary · may contain errors
MHC class II expression on pancreatic ductal adenocarcinoma (PDAC) malignant cells is a robust biomarker of local IFNγ production and intact IFNγ signaling.
AI summary · may contain errors
In treatment-naïve pancreatic ductal adenocarcinoma from 12 patients, relapse is linked to enrichment of immunosuppressive myeloid populations and depletion of cytotoxic CD8+ T cells.
- Open access
AI summary · may contain errors
Near-complete, haplotype-resolved assemblies of an early-passage hypodiploid pancreatic cancer cell line recapitulate all 35 karyotyped chromosomes and reveal 149 somatic SVs altering 939 kbp.
- Open access
- 4 cites
Browse JClub
Journals this month
- bioRxiv6586
- medRxiv1747
- PNAS583
- JAMA366
- Sci Adv330
- Cell Rep321
- Environ Res230
- BMJ216
- EHJ213
- Nat Commun185
- Plant Cell Environ177
- NAR176
- Science152
- Environ Pollution151
- New Phytol149
- NEJM148
- Lancet129
- Nature127
Topics moving, week to 18 Nov 2026
- Gut microbiota and health9
- Single-cell and spatial transcriptomics6
- CAR-T cell therapy research4
- Global Cancer Incidence and Screening3
- Lung Cancer Treatments and Mutations3
- Pancreatic and Hepatic Oncology Research3
- Antibiotic Resistance in Bacteria3
- Bacteriophages and microbial interactions3
- Diabetes Management and Education3
- Immune cells in cancer3
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
